The EIF2S1 Knockout HCT 116 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal cell population derived from the human colorectal carcinoma HCT 116 cell line, featuring targeted disruption of the EIF2S1 gene. This polyclonal knockout model provides a heterogeneous pool of cells carrying diverse loss-of-function edits in EIF2S1, enabling robust functional genetic studies without clonal selection artifacts. EIF2S1 encodes the alpha subunit of eukaryotic translation initiation factor 2 (eIF2??), a master regulator of protein synthesis and stress adaptation. By ablating eIF2?? expression, this knockout system effectively removes the central phosphoregulatory node of the integrated stress response (ISR), creating a powerful tool for dissecting translation-dependent signaling mechanisms.
The HCT 116 host cell line originates from a male patient with colorectal adenocarcinoma and serves as a widely used model for colorectal cancer (CRC) research. These epithelial cells harbor activating mutations in KRAS (G13D) and PIK3CA (H1047R), two oncogenic drivers that promote proliferation and survival signaling in CRC. Critically, HCT 116 cells are mismatch repair-deficient (MSI-H) due to epigenetic silencing of MLH1, rendering them hypermutable and representative of the microsatellite instability phenotype observed in 15% of sporadic colorectal tumors. This genetic context??combined with their adherent, rapid growth and susceptibility to genetic manipulation??makes HCT 116 an optimal background for examining the interplay between oncogenic signaling and cellular stress responses. The knockout of EIF2S1 in this setting allows researchers to interrogate how translational control intersects with common CRC driver mutations.
EIF2S1 (eIF2??) functions as the regulatory subunit of the eIF2 heterotrimer, which together with eIF2?? (EIF2S2) and eIF2?? (EIF2S3) delivers initiator methionyl-tRNA to the ribosome during translation initiation. Under diverse stresses??including amino acid deprivation, endoplasmic reticulum (ER) stress, viral infection, and heme deficiency??upstream kinases GCN2 (EIF2AK4), PERK (EIF2AK3), PKR (EIF2AK2), and HRI (EIF2AK1) phosphorylate eIF2?? at Ser51. Phosphorylated eIF2?? binds tightly to the eIF2B guanine nucleotide exchange factor, inhibiting its activity and globally suppressing translation initiation. This reduction in protein synthesis conserves resources and, paradoxically, facilitates selective translation of mRNAs with upstream open reading frames, most notably the transcription factor ATF4. ATF4 subsequently induces downstream targets including the pro-apoptotic factor CHOP (DDIT3) and the stress-recovery phosphatase GADD34 (PPP1R15A), which dephosphorylates eIF2?? to restore homeostasis. Disruption of EIF2S1 abolishes this entire regulatory cascade, eliminating phospho-eIF2??-mediated translation attenuation and ATF4-driven gene expression, thereby uncoupling stress sensing from adaptive and apoptotic outputs.
In the HCT 116 colorectal cancer model, EIF2S1 knockout has profound implications for understanding tumor biology and therapeutic response. CRC cells frequently encounter metabolic stress, hypoxia, and chemotherapeutic insults that trigger the ISR; the ability to modulate translation and promote ATF4-mediated survival programs often contributes to drug resistance and tumor progression. By removing the eIF2?? checkpoint, these polyclonal knockout cells become sensitized to ER stress and other insults, making them a valuable platform for studying mechanisms of stress-induced apoptosis and for identifying synthetic lethal interactions. Additionally, the KRAS/PIK3CA mutant background enhances the relevance of the model for testing targeted therapies that may synergize with ISR disruption, as oncogenic signaling pathways often converge on translation control via mTOR/eIF2 signaling axes. Researchers can thus investigate how CRC cells balance proliferation with stress resilience and explore whether ISR impairment represents a therapeutic vulnerability in MSI-H tumors.
Typical research applications employing these EIF2S1 knockout polyclonal HCT 116 cells span a wide spectrum of functional and mechanistic studies. Researchers can perform Western blotting to confirm loss of total eIF2?? and absence of phospho-eIF2??, and to assess ATF4 and CHOP induction in response to stressors such as tunicamycin or thapsigargin. Polysome profiling allows quantitative analysis of translation initiation rates and ribosome occupancy under stress conditions. Cell viability assays under pharmacologically induced ER stress enable dissection of apoptotic thresholds, while ATF4-luciferase reporter systems provide a sensitive readout of ISR activation. Global transcriptomic analyses via RNA-seq can reveal downstream gene expression changes resulting from EIF2S1 loss. This polyclonal knockout model is therefore an essential resource for researchers investigating the integrated stress response, translational control, cancer drug resistance, neurodegenerative disorders, and viral pathogenesis. For technical assistance or custom inquiries, please contact Ascent Research.
